OPTH
Optimi Health Corp.
NASDAQ · Basic Materials · Agricultural Inputs · CA
$4.78
+1.60%Jul 6, 2026, 19:53 UTC
Optimi Health shipped its third commercial psilocybin export to Australia.
Source:Jun 29, 2026, 13:00 UTC
Optimi Health completed the export of its 5mg psilocybin capsules to Australia for patients with treatment-resistant depression, marking its third commercial shipment since launching the product in September 2025.
Source:Jun 16, 2026, 16:37 UTC
Optimi Health Corp. launched two standardized microdose psilocybin finished drug products (1mg and 2mg) for clinical research.
Jun 10, 2026, 13:15 UTC
Optimi Health completed its first export of psilocybin to the United Kingdom for a Phase 2 clinical trial.
Source:Jun 8, 2026, 12:00 UTC
Optimi Health secures ibogaine supply and commences finished drug product development for encapsulated dosages of 50mg and 100mg.
Source: